Howard Levine

Howard Levine

Fundador en DNX Biopharmaceuticals, Inc. .

Health Technology
Consumer Services
Commercial Services

Perfil

Howard L.
Levine
is the founder of BPTC Holding, Inc. (founded in 1994) where he holds the title of President, CEO, Secretary, Treasurer & Director.
He is also the founder of DNX Biopharmaceuticals, Inc. (founded in 2014) where he holds the title of Director.
Dr. Levine currently holds the position of Director at Protein Sciences Corp., Triplebar Bio, Inc., and 3CC Management LLC.
In the past, Dr. Levine worked as a Director at XOMA Corp.
from 1986 to 1991 and as a Vice President at Repligen Corp.
from 1991 to 1994.
Dr. Levine obtained a doctorate degree from Harvard University in 1980.
He also holds an undergraduate degree from the University of Southern California (1975) and a doctorate degree from The University of Chicago (1978).

Cargos activos de Howard Levine

EmpresasCargoInicio
Director/Miembro de la Junta -
Director Ejecutivo 01/01/1994
Fundador 01/01/2014
Director/Miembro de la Junta -
Inversor de Capital Privado -
Todos los cargos activos de Howard Levine

Antiguos cargos conocidos de Howard Levine.

EmpresasCargoFin
REPLIGEN CORPORATION Presidente 02/01/1994
XOMA CORPORATION Director/Miembro de la Junta 02/01/1991
Ver el detalle de la experiencia de Howard Levine.

Formación de Howard Levine.

Harvard University Doctorate Degree
University of Southern California Undergraduate Degree
The University of Chicago Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Howard Levine.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
REPLIGEN CORPORATION

Health Technology

XOMA CORPORATION

Health Technology

Empresas privadas5

Health Technology

Commercial Services

Commercial Services

Finance

Commercial Services

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA